Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
230
Views
5
CrossRef citations to date
0
Altmetric
Commentaries

The role of ponatinib in chronic myeloid leukemia in the era of treatment free remission

Claire AndrewsDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
&
Jeffrey LiptonDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
Pages 3099-3101 | Received 24 Jul 2019, Accepted 16 Aug 2019, Published online: 26 Sep 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Umut Yilmaz & Ahmet Emre Eskazan. (2020) Moving on from 2013 to 2020 European LeukemiaNet recommendations for treating chronic myeloid leukemia: what has changed over the 7 years?. Expert Review of Hematology 13:10, pages 1035-1038.
Read now

Articles from other publishers (4)

Melissa F Djodikromo, Rosella PMG Hermens, Bart JF van den Bemt, Yolba Smit, Tim M Govers, Charlotte L Bekker & Nicole MA Blijlevens. (2023) Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial. BMC Cancer 23:1.
Crossref
Zehra Narlı Özdemir, Necati Alp Kılıçaslan, Musa Yılmaz & Ahmet Emre Eşkazan. (2022) Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities. International Journal of Hematology 117:1, pages 3-15.
Crossref
Yilin Chen, Jing Zou, Fanjun Cheng & Weiming Li. (2021) Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells. Frontiers in Oncology 11.
Crossref
A. Hochhaus, M. Baccarani, R. T. Silver, C. Schiffer, J. F. Apperley, F. Cervantes, R. E. Clark, J. E. Cortes, M. W. Deininger, F. Guilhot, H. Hjorth-Hansen, T. P. Hughes, J. J. W. M. Janssen, H. M. Kantarjian, D. W. Kim, R. A. Larson, J. H. Lipton, F. X. Mahon, J. Mayer, F. Nicolini, D. Niederwieser, F. Pane, J. P. Radich, D. Rea, J. Richter, G. Rosti, P. Rousselot, G. Saglio, S. Saußele, S. Soverini, J. L. Steegmann, A. Turkina, A. Zaritskey & R. Hehlmann. (2020) European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia 34:4, pages 966-984.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.